Grantham, Mayo, Van Otterloo & Co (GMO)
CVS icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s CVS Health CVS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-220,000
Closed -$13.7M – 566
2018
Q1 		$13.7M Buy
+220,000
New +$15.8M 0.08% 132

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CVS Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its CVS Health (CVS) stake by 15% in Q2 2026, selling an estimated $8.37M and leaving 541,115 shares worth $56M. The position accounts for 0.13% of the portfolio, ranked #64.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CVS in Q2 2013 and has held it in 42 quarters since. The position peaked at $241M in Q1 2016. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 541,115 shares of CVS Health worth $56M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 93,731 CVS Health shares in Q2 2026, an estimated $8.37M.
  • CVS Health made up 0.13% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #64 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CVS Health in Q2 2013 and has held it in 42 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s CVS Health position peaked at $241M in Q1 2016.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.